Patent ID: 9006214
Filing Date: 2015-04-14
Classification: A61K,A61P,Y10S

Abstract:
1. An ophthalmic composition adapted for the treatment of the eye which is the combination of a pharmaceutically acceptable active agent and an ophthalmic liquid carrier therefore, the liquid consisting essentially of water, colloidal oil droplets containing clear nano-size polar lipid which is nonionic polyoxyethylated castor oil or nonionic hydrogenated polyoxyethylated castor oil having a particle size of 1-50 nm, and gellan, which is buffered to a pH of 5-7.8, is free of cationic electrolytes, and has an osmolality of 250-400 mOsm/kg.H 2 O, said liquid being a clear liquid which forms a clear gel upon topical contact with the eye.